8N2-22489-61328
3 vaccinations
1 coded response
29 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 100 / NY
- Registered
- 2021-11-04
- Relationship
- Child or adolescent in my care
- Guardian
- 8WC-23509-01205
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-04
Registered in v-safe
-
2021-11-04
Dose 1 — Pfizer-BioNTech
- 2021-11-04
-
2021-11-05
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Site: Pain · Fever · Fatigue or tirednessAdult check-in
-
2021-11-06
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Site: Pain, Itching · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-07
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-11-08
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Fatigue or tirednessAdult check-in
- 2021-11-11
-
2021-11-20
Survey response — day 14, dose 1, dependentMedDRA: Headache, Nausea, Pyrexia, Rhinorrhoea, SARS-CoV-2 test negative, Upper respiratory tract infection, Upper-airway cough syndrome — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Upper Respiratory Tract Infection (headache, runny nose, nausea) with fever Nov 11-17, 2021. 2 negative rapid test and 1 negative SARS-COV2 PCR test. Fully recovered aside from post nasal drip.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-26
Dose 2 — Pfizer-BioNTech
-
2021-11-26
Health check-in — day 0, dose 2, dependentFeeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-11-27
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-11-28
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-11-29
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-12-01
- 2021-12-05
- 2021-12-12
- 2021-12-17
- 2021-12-24
- 2021-12-31
- 2022-01-07
- 2022-02-27
-
2022-05-25
Dose 3 — Pfizer-BioNTech
-
2022-05-26
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Fair · Site: Pain, Swelling, Itching · Headache, Fatigue or tirednessAdult check-in
-
2022-05-27
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · HeadacheAdult check-in
- 2022-05-29
- 2022-06-01
- 2022-06-14
- 2022-06-17
- 2022-06-22
- 2022-06-29
- 2022-07-08
- 2023-05-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-04 | Pfizer-BioNTech | No |
| 2 | 2021-11-26 | Pfizer-BioNTech | No |
| 3 | 2022-05-25 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 1, dependent
Symptoms: Upper Respiratory Tract Infection (headache, runny nose, nausea) with fever Nov 11-17, 2021. 2 negative rapid test and 1 negative SARS-COV2 PCR test. Fully recovered aside from post nasal drip.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release